TNFSF11 and plasma cell myeloma: One of the major clinical features of multiple myeloma is the development of osteolytic bone disease and, over recent years, there is increasing evidence to suggest that the dysregulation of the RANK/RANKL/OPG system is important in the pathogenesis of myeloma bone disease.